Media Library
Explore presentations, webinars and video content from hVIVO’s experts.
Gain deeper insight into our science, capabilities and approach to clinical development.
hVIVO H1 2026 Interim Results
hVIVO Acquires CRS Berlin
HY26 Trading Updates
FY25 Trading Updates
About Us
hVIVO is a science led drug development partner operating an integrated ecosystem that unifies specialist clinical sites, advanced laboratories, human challenge expertise, and early drug development consulting. This model enables sponsors to generate rigorous, decision ready human data earlier in development, reducing uncertainty and accelerating progression through Phase I and II trials. With world leading capabilities in respiratory and infectious disease, expertise in cardiometabolic areas, and the largest human challenge facilities globally, hVIVO supports a diverse international client base. Its integrated approach provides the clarity, speed, and reliability required to advance new medicines with confidence.
Press Kit
Access our press kit for essential company information, including corporate overviews, key facts, leadership profiles and brand assets. Designed to support journalists, partners and stakeholders, this resource provides accurate, up-to-date materials to help you tell the hVIVO story with confidence.
Investors
Access hVIVO’s investor hub for the latest financial results, reports, and shareholder information. Stay up to date with company performance, regulatory announcements, and key updates. Visit the investor page to explore detailed insights and resources supporting informed decision-making and a deeper understanding of our growth strategy.